Join the Meet the Professor session with Prof. Man Mohan Mehndiratta (India) who will speak about the “Approach to Stroke in the Young”. This is an exciting opportunity for an open and live discussion with the expert in this field.

The lecture on the topic will be followed by a live discussion with the professor. Some of the questions which will be addressed are:
- What is the incidence of stroke in Young in the world?
- What percentage of ischemic strokes constitute cryptogenic stroke?
- What are the associated factors in HIV infected patients who suffer a young stroke?
- What is the percentage of young stroke in India and the Western world?
- Causes of cryptogenic stroke
- Cardio embolism as a cause of young stroke amounts to what percentage of all strokes?

Convenor: Pooja Khatri (USA)
Convenor: George Ntaios (Greece)

Do We Need Perfusion Imaging to Guide MT in Extended Time Window
Yes: Götz Thomalla (Germany)
No: Mayank Goyal (Canada)

Patients with Severe Stroke Should be Directly Transferred to an Interventional Center (Bypassing Smaller Non-Interventional Centers)
Yes: Blanca Fuentes (Spain)
No: Marios Psychogios (Switzerland)

Acute Intracranial Stenting Should be Performed as Rescue Treatment in Failed Recanalization
Yes: Rene Chapot (Germany)
No: Phil White (UK)

Convenor: Ben Bray (UK)
Convenor: Valery Feigin (New Zealand)

Using Big Data for Stroke Research
Ben Bray (UK)

Using Technology for N of 1 Trials
Sandosh Padmanabhan (UK)

Cognitive Computing and Applications in Stroke Care
Catherine Sudlow (UK)

Reducing the Risk of Stroke – The Role of Apps
Valery Feigin (New Zealand)

Using Big Data to Measure Outcome After Stroke
Monique Kilkenny (Australia)

First Steps When Planning a Career as a Clinician Scientist
Karin Klijn, Netherlands

Choosing a Valuable Research Mentor
Peter Sandercock, United Kingdom

Targeted Delivery of RTPA With an Untethered Steerable Microdevice
Christophe Chautems, Switzerland

Coordinated Patient Care Via Mobilephone Based Tele-medicine to Improve Medication Persistence and Stroke Awareness in Adult Stroke Patients: A Randomized Trial
Yu Zhou, China

Patent Foramen Ovale As a Marker of Altered Vascular Development in Migraine with Aura Patients
Matteo Paolucci, Italy

An In-depth Analysis of the Influence of Visuospatial Neglect on Motor Recovery Post-stroke: Study Protocol
Elissa Embrechts, Belgium

General Advices

Convenor: Jesse Dawson (UK)
Convenor: Marc Fisher (USA)

- Welcome Message
- Large Clinical Trials

Convenor: Werner Hacke (Germany)
Convenor: Martin Dichgans (Germany)

Large Clinical Trials
WSO Award for Contribution to Clinical Stroke Research
WSO Award for Services to Stroke

Convenor: Julie Bernhardt (Australia)
Convenor: Friedhelm Hummel (Switzerland)

Brain Repair is the Right Target to Improve Outcome
Tomoko Kitago (USA)

Brain Repair Does Not Work, Reorganisation is Key
Belen Rubio Ballester (Spain)

The More the Better - More Therapy Can Improve Recovery
Nick Ward (UK)

It's Just Spontaneous Recovery - More Therapy Makes No Difference
Gert Kwakkel (Netherlands)

Non-Invasive Brain Stimulation is Getting Close to Clinical Application for Stroke
Alexander Thiel (Canada)

Non-Invasive Brain Stimulation for Stroke Recovery Has Failed
Christian Gerloff (Germany)

Convenor: Bart van der Worp (Netherlands)
Convenor: Michael Brainin (Austria)

- Large Clinical Trials
- WSO Presidential Award
- WSO Leadership in Stroke Award
- ESO AngelsAwards

Convenor: Gregory Lip (UK)
Convenor: Marc Fisher (USA)

Atrial Fibrillation Detection and Burden
Marc Fisher (USA)

Stratification of Ischaemic and Haemorrhagic Stroke Risk in AF Patients
Mahmut Edip Gurol (USA)

Medical Management to Reduce Stroke Risk in AF Patients
John Camm (UK)

Nonpharmacological Approaches to Reduce Stroke Risk in AF Patients
Renate Schnabel (Germany)

AF and Cognitive Function
Gregory Lip (UK)

Convenor: Mira Katan (Switzerland)
Convenor: Peter Schellinger (Germany)

Antiplatelets Should Be Used in People with WMH but No History of Stroke
Yes: Claudio Sacks (Chile)
No: María Alonso de Leciñana (Spain)

Genetic Risk Profiling to Guide Primary Prevention of Stroke; Ready for Prime Time?
Yes: Gad Abraham (Australia)
No: Gisele Sampaio Silva (Brazil)

Pioglitazone Should Be Used to Prevent Recurrent Ischaemic Stroke in People with Insulin Resistance
Yes: Walter Kernan (USA)
No: Jonathan Hewitt (UK)

Convenor: Alastair Webb (UK)
Convenor: Alexander Thiel (Canada)

- Large Clinical Trials
- Barbro Johansson Award
- Announce Winners of E-Poster Prize
- Closing Message

Convenor: Jens Fiehler (Germany)
Convenor: Raul Nogueira (USA)

Imaging in The Pre-Hospital Phase – A Look to The Future
Geoffrey Donnan (Australia)

Stroke Imaging: How to Predict Futile Recanalisation?
Raul Nogueira (USA)

ICI2b or TICI3; Time to Redefine Successful Reperfusion to Conclude Intervention
Johannes Kaesmacher (Switzerland)

The Role of First Pass Recanalization
Bertrand Lapergue (France)

Stenting in Tandem Occlusions: A Bail or Thread?
Pasquale Mordasini (Switzerland)

- What is the pathophysiology of COVID-19 infection and its implications for management and treatment?

- Global Impact of the COVID-19 Pandemic on Stroke Hospitalizations and Acute Stroke Treatment
Raul Nogueira, USA

- Reorganisation of Acute Stroke Management During COVID-19 Lockdown
Blanca Fuentes, Spain

- Continuing and Maximizing ``Telemedicine`` in Stroke Services: During and Post-COVID Pandemic
Gary Ford, UK

- Life-After Stroke: With Special Reference to COVID Pandemic
David Hargroves, UK

- Rehabilitation services during the COVID Pandemic

- Rehabilitation for Serious COVID: Physiotherapist as Patient
Karl Schurr and Annie McClusky, Australia

- Neurological and Neuropsychiatric Complications of COVID-19

- Are Patients with COVID-19 and Acute Ischemic Stroke Different? Characteristics and Outcomes
George Ntaios, Greece

- Next Frontiers in Endovascular Thrombectomy and Some Lessons During the COVID Era
Bernard Yan, Australia

- Mechanisms – Insights From Genetic Studies
Dipender Gill, UK